Detalhe da pesquisa
1.
A clinical review of structural damage in psoriatic arthritis for dermatologists: From pathogenesis to ongoing controversies.
J Am Acad Dermatol
; 90(2): 349-357, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37852305
2.
Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysis.
Rheumatology (Oxford)
; 62(4): 1417-1425, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36102818
3.
Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis.
Rheumatology (Oxford)
; 60(5): 2109-2121, 2021 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33844022
4.
Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?'
Ann Rheum Dis
; 82(8): e187, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35487679
5.
Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE Study.
J Clin Rheumatol
; 28(8): 420-423, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35649533
6.
BASDAI versus ASDAS in evaluating axial involvement in patients with psoriatic arthritis: a pooled analysis of two phase 3 studies.
Rheumatol Adv Pract
; 8(2): rkae058, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38765190
7.
Earlier clinical response predicts low rates of radiographic progression in biologic-naïve patients with active psoriatic arthritis receiving guselkumab treatment.
Clin Rheumatol
; 43(1): 241-249, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37787903
8.
Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis.
Drug Saf
; 47(1): 39-57, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37906417
9.
Improvements in Patient-Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real-World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
ACR Open Rheumatol
; 6(5): 304-311, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38417434
10.
Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study.
BMC Rheumatol
; 8(1): 6, 2024 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310261
11.
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who had inadequate efficacy and/or intolerance to one prior tumor necrosis factor inhibitor: study protocol for SOLSTICE, a phase 3B, multicenter, randomized, double-blind, placebo-controlled study.
BMC Rheumatol
; 8(1): 20, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38773563
12.
Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study.
Clin Rheumatol
; 2024 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38844682
13.
Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor-Inadequate Responders With Active Psoriatic Arthritis.
Arthritis Rheumatol
; 76(6): 894-904, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38253404
14.
The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation.
Semin Arthritis Rheum
; 65: 152378, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310657
15.
Kinase inhibitors: a new tool for the treatment of rheumatoid arthritis.
Clin Immunol
; 148(1): 66-78, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23651870
16.
Rheumatic manifestations of endocrine disease.
Curr Opin Rheumatol
; 25(1): 37-43, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23159916
17.
Efficacy of Guselkumab in Treating Nails, Scalp, Hands, and Feet in Patients with Psoriasis and Self-reported Psoriatic Arthritis.
Dermatol Ther (Heidelb)
; 13(11): 2859-2868, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37713133
18.
Impact of Physician-Defined Flares on Quality of Life and Work Impairment: An International Survey of 2238 Patients With Psoriatic Arthritis.
J Rheumatol
; 50(1): 76-83, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35970528
19.
Women With Psoriatic Arthritis Experience Higher Disease Burden Than Men: Findings From a Real-World Survey in the United States and Europe.
J Rheumatol
; 50(2): 192-196, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35970531
20.
Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study.
Arthritis Res Ther
; 25(1): 150, 2023 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37587493